phytosphingosine has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gedon, NKY; Kania, SA; Kühnle, C; Kühnle, HF; Mueller, RS; Raizner, NT; Zablotski, Y | 1 |
| Jung, YG; Kim, BH; Kim, S; Kim, TY; Lee, JM | 1 |
2 other study(ies) available for phytosphingosine and Dermatitis
| Article | Year |
|---|---|
Epidemiological observations on pastern dermatitis in young horses and evaluation of essential fatty acid spot-on applications with or without phytosphingosine as prophylactic treatment.
Topics: Animals; Dermatitis; Fatty Acids; Horse Diseases; Horses; Sphingosine | 2022 |
Phytosphingosine derivatives ameliorate skin inflammation by inhibiting NF-κB and JAK/STAT signaling in keratinocytes and mice.
Topics: Adult; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Survival; Dermatitis; Humans; Inflammation; Interleukin-23; Janus Kinase 1; Keratinocytes; Leukocytes, Mononuclear; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Psoriasis; Signal Transduction; Skin; Sphingosine; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2014 |